MRC Molecular Haematology Unit
At the MRC Molecular Haematology Unit, we aim to understand how stem cells produce mature blood cells in a healthy context, and how this process is perturbed in common blood disorders.
MRC MHU includes 14 research teams with over 140 scientists who share a common goal, to improve the prognosis of patients with inherited and acquired blood diseases.
This is an exciting time for the field of haematology. The -omics revolution is enabling scientists to unravel the complex molecular processes governing biology at unprecedented speed. At the MRC MHU our teams are committed to applying such cutting-edge techniques to better understand the molecular basis of blood diseases, and to develop treatments to improve the lives of patients. - Professor KJ Patel
Latest publications
Paediatric traumatic brain injury: clinical presentation, treatment approaches, management strategies, and outcomes. Insights from the CENTER-TBI study
Journal article
Graziano F. et al, (2026), Journal of Anesthesia Analgesia and Critical Care, 6
Can It Happen Again? Using Co-Produced Theatre to Explore the Challenges Faced by Couples Considering Pregnancy After a De Novo Genetic Diagnosis in a Child.
Journal article
Kay A. et al, (2026), Health Expect, 29
Coronary Inflammation Is Associated With Plaque Progression in Men With HIV.
Journal article
Nasrallah N. et al, (2026), Circ Cardiovasc Imaging
Recombinant shingles vaccination and the risk of cardiovascular events.
Journal article
Corsi-Zuelli F. et al, (2026), Nat Med
Zone Equalisation Normalisation for Improved Alignment of Epigenetic Signal.
Journal article
Wilson T. et al, (2026), Bioinformatics